Tailor-Made Cancer Drugs
pmineiro writes "A researcher at Washington University in St. Louis has developed a method for delivering an inactive drug complex into the body, which is only activated by certain messenger RNA sequences. This allows a drug to be selectively activated only in certain cellular contexts, e.g., cancer or HIV infection."
This is very interesting. Any other electrical engineers out there wish they had a biology background when they read stuff like this?
Why stick up for big business?